Applied Therapeutics News and Activities

Applied Therapeutics is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Applied Therapeutics is a company listed under the stock ticker APLT (US).

View the org chart displaying its 17 main executives

Most searched biographies at Applied Therapeutics

• Les Funtleyder, Interim Chief Executive Officer and Chief Financia...
• Stacy Kanter, Director
• Teena Lerner, Director

Popular executive movements at Applied Therapeutics

• Odd Baumgartner has joined the company as Chief Regulatory Officer  (posted on March 21 2025).
• Reena Colacot has joined the company as Vice President, Head of Quality  (posted on January 21 2025).
• Shoshana Shendelman, Chief Executive Officer and Chairman of the Board, has left the company  (posted on December 20 2024).

Click here to view some more movements at Applied Therapeutics

Create your alert
to follow the executive moves at Applied Therapeutics.

Applied Therapeutics has 2,350 competitors including Astellas Gene Therapies (United States (USA)), Eurofins (Luxembourg) and Lonza (Switzerland).

Popular M&A news in Biotechnology

• Eli Lilly has announced the acquisition of Verve Therapeutics  (posted on June 17 2025).
• Sirius Therapeutics has just announced a $50 Million fundraising (posted on June 16 2025).
• BioNTech has announced the acquisition of CureVac  (posted on June 12 2025).

Popular contacts in Biotechnology

• Sandra Smith - Senior Vice President, Clinical Solutions & Strategic Partnerships at WIRB-Copernicus Group
• Jasbir Seehra - Chief Executive Officer and Chairman of the Board at Keros Therapeutics
• Deepika Verma - Associate Director of Data Science and Digitalization at Wheeler Bio

Learn more about the Biotechnology industry

Press releases by Applied Therapeutics

• Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality | Applied Therapeutics
• Applied Therapeutics Appoints John H. Johnson as Executive Chairman | Applied Therapeutics
• Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia | Applied Therapeutics
• Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference | Applied Therapeutics
• Applied Therapeutics Reports Third Quarter 2024 Financial Results | Applied Therapeutics
• Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia | Applied Therapeutics
• Applied Therapeutics to Participate in Upcoming Investor Conferences | Applied Therapeutics
• Applied Therapeutics Reports Second Quarter 2024 Financial Results | Applied Therapeutics
• Applied Therapeutics Added to Russell 3000® Index | Applied Therapeutics
• Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference | Applied Therapeutics
• View more press releases Close

Social media about Applied Therapeutics

• Applied Therapeutics on Wikipedia, Google News & Yahoo Finance
• Applied Therapeutics on LinkedIn, Twitter & YouTube